Wilson Therapeutics AB (WTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Wilson Therapeutics AB (Wilson Therapeutics), a subsidiary of Alexion Pharma Nordics AB, is a biopharmaceutical company that develops novel therapies for patients with rare copper-mediated disorders. The companys lead product includes WTX101 is a copper-protein-binding agent, which is used for the treatment for wilson disease. Its product provides an alternative copper-protein transport mechanism, copper-protein complexes, de-toxify free copper and biliary excretion of copper. Wilson Therapeutics lead product is also used for the treatment of other medical conditions including amyotrophic lateral sclerosis. The company conducts clinical trials for developing the treatment of wilson disease. Wilson Therapeutics is headquartered in Stockholm, Sweden.

Wilson Therapeutics AB (WTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Wilson Therapeutics AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Wilson Therapeutics Acquires Decuprate from Tactic Pharma 10
Venture Financing 11
Wilson Therapeutics Raises US$40 Million In Series B Financing 11
Licensing Agreements 13
Wilson Therapeutics Enters into Licensing Agreement with University of Michigan 13
Equity Offering 14
Wilson Therapeutics Raises USD29 Million in Private Placement of Shares 14
Wilson Therapeutics Raises USD48 Million in IPO 16
Acquisition 18
Alexion Acquires Wilson Therapeutics for USD852 Million 18
Wilson Therapeutics Acquires TTM Europe Development from Medical Need Europe for USD6.2 Million 20
Wilson Therapeutics AB - Key Competitors 21
Wilson Therapeutics AB - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
May 16, 2018: Wilson Therapeutics: Interim report January 1March 31, 2018 23
Feb 21, 2018: Wilson Therapeutics Year-End Report 2017 24
Nov 23, 2017: Wilson Therapeutics Interim Report January 1September 30, 2017 25
Aug 24, 2017: Wilson Therapeutics: Interim Report January 1 June 30, 2017 26
Corporate Communications 27
Jun 01, 2018: Delisting of Wilson Therapeutics 27
May 25, 2018: Wilson Therapeutics applies for delisting 28
Nov 09, 2017: Wilson Therapeutics Nomination Committee appointed 29
May 22, 2017: Wilson Therapeutics Strengthens its Board of Directors by the Appointments of Birgitte Volck and Bjorn Odlander 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List Of Tables


Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Wilson Therapeutics AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Wilson Therapeutics AB, Deals By Therapy Area, 2012 to YTD 2018 8
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Wilson Therapeutics Acquires Decuprate from Tactic Pharma 10
Wilson Therapeutics Raises US$40 Million In Series B Financing 11
Wilson Therapeutics Enters into Licensing Agreement with University of Michigan 13
Wilson Therapeutics Raises USD29 Million in Private Placement of Shares 14
Wilson Therapeutics Raises USD48 Million in IPO 16
Alexion Acquires Wilson Therapeutics for USD852 Million 18
Wilson Therapeutics Acquires TTM Europe Development from Medical Need Europe for USD6.2 Million 20
Wilson Therapeutics AB, Key Competitors 21
Wilson Therapeutics AB, Subsidiaries 22

List Of Figures


Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Wilson Therapeutics AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Wilson Therapeutics AB (WTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Wilson Therapeutics AB (Wilson Therapeutics), a subsidiary of Alexion Pharma Nordics AB, is a biopharmaceutical company that develops novel therapies for patients with rare copper-mediated disorders. The companys lead product

USD 250 View Report

Kennedy-Wilson Holdings Inc Strategic Analysis Review- Kennedy-Wilson Holdings Inc SWOT, Outlook, Operations and Financial Profile

Kennedy-Wilson Holdings Inc Company Profile provides strategic analysis of Kennedy-Wilson Holdings Inc Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth

USD 200 View Report

Calliditas Therapeutics AB (CALTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Calliditas Therapeutics AB (Calliditas Therapeutics), formerly Pharmalink AB is a pharmaceutical company that develops, identifies, and commercializes pharmaceutical products for niche indications. The companys pipeline products include Busulipo that is

USD 250 View Report

Calliditas Therapeutics AB - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Calliditas Therapeutics AB (Calliditas Therapeutics), formerly Pharmalink AB is a pharmaceutical company that develops, identifies, and commercializes pharmaceutical products for niche indications. The companys pipeline products include Busulipo that is

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available